Department of Neurology, Jingzhou First People's Hospital, The First Affiliated Hospital of Yangtze University, Jingzhou City, Hubei Province, 434000, China.
Curr Neurovasc Res. 2020;17(1):86-92. doi: 10.2174/1567202617666200117103931.
Alzheimer's disease (AD) is the most common neurodegenerative disease, and the accumulation of amyloid-β is the initial process in AD. MicroRNAs (miRNAs) are widely known as key regulators of the accumulation of amyloid-β in AD. This study analyzed the potential effects and possible internal mechanisms of miR-340 on AD.
The expression of miR-340 in senescence-accelerated mouse prone-8 (SAMP8) mouse and senescence-accelerated mice/resistant-1 (SAMR1) mouse was evaluated by qRT-PCR (quantitative real-time polymerase chain reaction). The expression of β-site amyloid precursor protein cleaving enzyme 1 (BACE1) was determined by qRT-PCR and western blot. The binding ability between miR-340 and BACE1 was verified by dual-luciferase reporter assay. In vitro cell model of AD was established in human neuroblastoma SH-SY5Y cells transfected with Swedish mutant form of amyloid precursor protein (APPswe). The effect of miR-340 on the accumulation of amyloid- β was investigated by western blot analysis. Flow cytometry was conducted to detect cell apoptosis.
MiR-340 was down-regulated in the hippocampus of AD model SAMP8 mouse compared to SAMR1 mouse, while BACE1 was up-regulated in SAMP8, suggesting a negative correlation between miR-340 and BACE1 in SAMP8 mouse. MiR-340 could directly bind with BACE1, and over-expression of miR-340 decreased expression of BACE1 in SH-SY5Y/APPswe cells. MiR- 340 reduced the accumulation of amyloid-β and suppressed cell apoptosis through targeting BACE1 in SH-SY5Y/APPswe cells.
MiR-340 was downregulated in AD and reduced the accumulation of amyloid-β through targeting BACE1, suggesting a potential therapeutic target for AD.
阿尔茨海默病(AD)是最常见的神经退行性疾病,淀粉样β的积累是 AD 的初始过程。 microRNAs(miRNAs)被广泛认为是 AD 中淀粉样β积累的关键调节因子。本研究分析了 miR-340 对 AD 的潜在影响和可能的内在机制。
通过 qRT-PCR(实时定量聚合酶链反应)评估 miR-340 在快速老化小鼠品系 8(SAMP8)和快速老化小鼠/抗性 1(SAMR1)小鼠中的表达。通过 qRT-PCR 和 Western blot 测定 β-位点淀粉样前体蛋白裂解酶 1(BACE1)的表达。通过双荧光素酶报告基因实验验证 miR-340 与 BACE1 的结合能力。通过转染瑞典突变型淀粉样前体蛋白(APPswe)的人神经母细胞瘤 SH-SY5Y 细胞建立 AD 的体外细胞模型。通过 Western blot 分析研究 miR-340 对淀粉样β积累的影响。通过流式细胞术检测细胞凋亡。
与 SAMR1 小鼠相比,AD 模型 SAMP8 小鼠海马中的 miR-340 下调,而 BACE1 上调,提示 SAMP8 小鼠中 miR-340 与 BACE1 呈负相关。miR-340 可直接与 BACE1 结合,过表达 miR-340 可降低 SH-SY5Y/APPswe 细胞中 BACE1 的表达。miR-340 通过靶向 BACE1 减少 SH-SY5Y/APPswe 细胞中淀粉样β的积累并抑制细胞凋亡。
AD 中 miR-340 下调,通过靶向 BACE1 减少淀粉样β的积累,提示其可能是 AD 的潜在治疗靶点。